Latest Stock Buy or Sell?
Today, The Panic-Proof Portfolio (Stockchase Research) and Stockchase Discover commented about whether JWEL-T, ABBV-N, ABT-N, AMD-Q, MAN-N, HAS-Q are stocks to buy or sell.
- Page 1/4
TOP PICK
Stockchase Research Editor: Michael O'Reilly Although recently reported revenue missed projected targets for the quarter, margins are expanding thanks to cost savings. Earnings by this toy manufacturer beat expectations by over 20% and support a ROE of 21%. We like that cash reserves grew in the quarter despite retiring debt. It pays a good dividend that is projected to be less than 50% of cash flow next year. We recommend placing a stop loss at $69, looking to achieve $108 -- upside potential over 30%. Yield 3.53% (Analysts’ price target is $108.18)
0
$80.480
Unknown
TOP PICK
Stockchase Research Editor: Michael O'Reilly This staffing and employment services company operates in 75 countries in 2200 offices, providing recruitment, career development and other human resources services. Recently reported earnings per share beat expectations by 20%. Demand for their services will further intensify as companies emerge from the pandemic. It trades at 1.8x book value and only 11x earnings. Its dividend is backed by a payout ratio under 40% of cash flow. We recommend placing a stop loss at $63.50, looking to achieve $97 -- upside potential over 21%. Yield 3.56% (Analysts’ price target is $96.70)
consulting
TOP PICK
Stockchase Research Editor: Michael O'Reilly The $127 billion market cap developer of microprocessors expects 20% revenue growth and earnings growth of 24% annually over the next five years. Recently reported earnings beat expectations by over 20% and support a 20% ROE. We like how it is building cash reserves while buying back shares. We recommend placing a stop loss at $68, looking to achieve $130 -- upside potential over 50%. Yield 0% (Analysts’ price target is $130.51)
electrical / electronic
BUY
Allan Tong’s Discover Picks Abbott stocks trade at a 25.18x PE at a low 0.74 beta, and pays a 1.73% dividend. Its valuation is significantly lower than peers Stryker (36.4x) and Becton Dickinson (37.3x) while its profit margin scores much higher at 17.35% vs. 11.56% and 9.59% respectively. ROI is also comparably higher while Abbott stock’s 1.73% divvy is in-line with this sector (and safe at a 42.17% payout ratio). Back to earnings: Abbott stocks have beaten their last four quarters handily. Read Our 3 defensive healthcare stocks picks for our full analysis.
biotechnology / pharmaceutical
BUY
Allan Tong’s Discover Picks When I last recommended AbbVie in mid-April, this popular dividend-payer was trading at 52-week highs nearing $175. In three months, shares had raced from $135, so $175 was unsustainable. Last month, shares dipped below $138 and since then it has trended around a reasonable $150. I still like AbbVie stocks. It pays a solid 3.75% dividend, trades below 22x earnings, is safe at a 0.75 beta in a rockly market, and its shares have risen 120% in five years. Read Our 3 defensive healthcare stocks picks for our full analysis.
0
BUY
Allan Tong’s Discover Picks Vitamins are defensive, something you need in today’s uncertain markets where the street keeps chattering about recession. The street likes JWEL stocks with seven buys and no holds or sells and expects about 30% upside at a $45.64 price target. JWEL stocks are still a ways off their $41.70 52-week high. Read Our 3 defensive healthcare stocks picks for our full analysis.
0
COMMENT
U.S. corporate earnings so far have flagged a strong USD as a headwind. Will earnings be revised downward? JNJ, which she owns, is maintaining their earnings guidance this year, which is encouraging, because it means earnings in general are growing. The US banks state that the consumer is still healthy, loan balances remain healthy, card balances are growing and default rates are low. However, it remains uncertain the impact of higher interest rates on consumer spending and lending. JPM is raising loan provisions. Generally speaking so far according to earnings, the consumer remains strong. A lot of pessimism in the market now can be a positive, contrarian indicator. Also, there's a lot of cash on the sidelines which drives rallies like today.
Unknown
